P5-19-13: A Randomized Phase II Trial of First-Line Metastatic Breast Cancer (MBC) Patients: Sub-Set Analysis of Albumin-Bound Paclitaxel (ab-pac) Given Weekly at 150 mg/m2.

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

Randomized Phase II Trial of Weekly vs. Every 2 Weeks vs. Every 3 Weeks Nanoparticle Albumin-Bound Paclitaxel With Bevacizumab as First-Line Chemotherapy for Metastatic Breast Cancer

Clinical Breast Cancer ◽

10.1016/j.clbc.2013.02.008 ◽

2013 ◽

Vol 13 (4) ◽

pp. 239-246.e1 ◽

Cited By ~ 19

Author(s):

Andrew D. Seidman ◽

Alison K. Conlin ◽

Ariadne Bach ◽

Mary Ellen Moynahan ◽

Diana Lake ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

Randomized Phase Ii ◽

Line Chemotherapy

P5-19-03: Albumin-Bound Paclitaxel (ab-pac) Versus Docetaxel for First-Line Treatment of Metastatic Breast Cancer (MBC): Overall Survival and Safety Analysis of a Randomized Phase II Trial.

10.1158/0008-5472.sabcs11-p5-19-03 ◽

2011 ◽

Cited By ~ 1

Author(s):

WJ Gradishar ◽

D Krasnojon ◽

S Cheporov ◽

AN Makhson ◽

GM Manikhas ◽

...

Keyword(s):

Breast Cancer ◽

Overall Survival ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽

Randomized Phase Ii ◽

First Line Treatment

P1-14-01: Randomized Phase II Trial of Weekly vs. q 2-Weekly vs. q 3-Weekly Nanoparticle Albumin-Bound Paclitaxel with Bevacizumab as First-Line Therapy for Metastatic Breast Cancer.

10.1158/0008-5472.sabcs11-p1-14-01 ◽

2011 ◽

Author(s):

AD Seidman ◽

AK Conlin ◽

A Bach ◽

A Forero-Torres ◽

G Wright ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Vinorelbine, methotrexate and fluorouracil (VMF) as first-line therapy in metastatic breast cancer: a randomized phase II trial

Annals of Oncology ◽

10.1093/annonc/mdg199 ◽

2003 ◽

Vol 14 (5) ◽

pp. 699-703 ◽

Cited By ~ 5

Author(s):

I. Elomaa ◽

H. Joensuu ◽

C. Blomqvist

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Randomized Phase II Trial Comparing Exemestane to Tamoxifen for First-Line Hormonal Therapy of Postmenopausal Patients with Metastatic Breast Cancer

Clinical Breast Cancer ◽

10.1016/s1526-8209(11)70304-4 ◽

2001 ◽

Vol 2 (2) ◽

pp. 110-112 ◽

Cited By ~ 1

Author(s):

Kavita Maung ◽

Joyce O'Shaughnessy

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Hormonal Therapy ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

5001 CIRG/TORI 010: first analysis of a randomized phase II trial of motesanib plus weekly paclitaxel (P) as first line therapy in HER2-negative metastatic breast cancer (MBC)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)70893-6 ◽

2009 ◽

Vol 7 (2) ◽

pp. 260

Author(s):

M. Martin ◽

S. Hurvitz ◽

J. Kennedy ◽

J. Forbes ◽

H. Roché ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Weekly Paclitaxel ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

CIRG/TORI 010: 10-Month Analysis of a Randomized Phase II Trial of Motesanib Plus Weekly Paclitaxel as First Line Therapy in HER2-Negative Metastatic Breast Cancer (MBC).

10.1158/0008-5472.sabcs-09-47 ◽

2009 ◽

Cited By ~ 3

Author(s):

J. Mackey ◽

S. Hurvitz ◽

J. Crown ◽

J. Forbes ◽

H. Roché ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Weekly Paclitaxel ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

SABRE-B: a randomized phase II trial evaluating the safety and efficacy of combining sunitinib (S) with paclitaxel (P) + bevacizumab (B) as first-line treatment for HER2-negative metastatic breast cancer (MBC): final results.

10.1158/0008-5472.sabcs-3126 ◽

2009 ◽

Cited By ~ 3

Author(s):

E Mayer ◽

M Kozloff ◽

R Qamar ◽

B Klencke ◽

J Balkissoon ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽

Safety And Efficacy ◽

Randomized Phase Ii ◽

First Line Treatment

Phase II Trial of Weekly Vinorelbine and Trastuzumab as First‐Line Therapy in Patients with HER2 + Metastatic Breast Cancer

The Oncologist ◽

10.1634/theoncologist.7-5-410 ◽

2002 ◽

Vol 7 (5) ◽

pp. 410-417 ◽

Cited By ~ 107

Author(s):

Mohammad Jahanzeb ◽

Joanne E. Mortimer ◽

Furhan Yunus ◽

David H. Irwin ◽

James Speyer ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

First Line Therapy ◽

Line Therapy

First-line chemotherapy of advanced or metastatic breast cancer (MBC) with docetaxel and doxorubicin in Indonesia: results from A phase II trial

Medical Journal of Indonesia ◽

10.13181/mji.v14i1.166 ◽

2005 ◽

pp. 20

Author(s):

Abdulmuthalib Abdulmuthalib ◽

Idral Darwis ◽

Nugroho Prayogo ◽

Sutjipto Sutjipto

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

Line Chemotherapy